| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 08/16/2001 | WO2000056302A3 Vanadium (iv) complexes containing catacholate ligand and having spermicidal activity |
| 08/16/2001 | WO2000047551A3 Inhibitors of aspartyl protease |
| 08/16/2001 | US20010014753 Carbonylation of hydroxyaromatic compound with oxygen and carbon monoxide with catalyst system of palladium, bromide or chloride salt, biphosphine, and lead bromophenoxide; nontoxic polycarbonate preparation |
| 08/16/2001 | US20010014742 Water-soluble prodrugs of azole compounds |
| 08/16/2001 | US20010014706 Heat curing; adhesives |
| 08/16/2001 | US20010014647 Hydrocyanation of butadiene to adiponitrile |
| 08/16/2001 | US20010014646 Bidentate ligands bonded to nickel, palladium, cobalt, or iron, and optionally, one or more neutral Lewis acids |
| 08/16/2001 | EP1123302A1 Organophosphines |
| 08/16/2001 | EP1123301A1 Chelating agents for radioimmunotherapy |
| 08/16/2001 | EP1123300A1 Phosphoric acid esters |
| 08/16/2001 | EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 08/16/2001 | EP1123105A1 Solid phase quenching systems |
| 08/16/2001 | EP0937097B1 Compositions and methods for immobilizing nucleic acids to solid supports |
| 08/16/2001 | EP0670729B1 Use of insulin-like growth factors and analogs for TREATING RETINAL NEURONAL DISORDERS |
| 08/16/2001 | DE10005794A1 Verbindungen des Phosphors, Arsens und des Antimons Compounds of phosphorus, arsenic and antimony, |
| 08/16/2001 | DE10005768A1 Polymers containing a tetrakis-halogenalkyl-arylene-diphosphate ester are useful for the production of low-flammability polyurethane foams for upholstery and insulation. |
| 08/16/2001 | CA2399431A1 Phosphor, arsenic and antimony compounds based upon diaryl-anellated bicyclo [2.2.n] parent substances and catalysts containing same |
| 08/16/2001 | CA2397993A1 Dehydroamino acids |
| 08/16/2001 | CA2366522A1 Non-naturally occurring nucleic acid compositions, their use for the preparation of formulations useful for transfecting a nucleic acid into cells and applications |
| 08/15/2001 | CN1308634A Process for prepairng N-phosphonomethyl iminodiacatio acid |
| 08/15/2001 | CN1308633A Preparation of N-phosphonomethylglycine salts |
| 08/15/2001 | CN1308627A 11-Aryl-benzo[b]naphtho[2,3-d]furans and 11-aryl-aryl-benzo[b]anphtho[2,3-d]thiophenes useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308604A 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308082A Preparation process of N-amino-1-hydroxyalkylene-1,1-diphosphonic acid |
| 08/15/2001 | CN1308081A Organometallic acyl-aryl phosphine |
| 08/15/2001 | CN1308062A 1-substituted-N-sulfinyl-2-aziridine methylenimine and its preparation and use |
| 08/15/2001 | CN1307870A Crystallized pirimiphos-methyl composite and its preparation and usage |
| 08/15/2001 | CN1069645C Preparation of dichloro pentaerythritol phosphite |
| 08/14/2001 | US6274774 Process for preparing aldehydes in the presence of an aqueous phase containing rhodium and sulphonated triarylphosphines as catalyst |
| 08/14/2001 | US6274760 Catalytic decomposition of (phosphonomethyl)amine oxide |
| 08/14/2001 | US6274756 From 2,4,6-trimethylnonanol |
| 08/14/2001 | US6274753 Process for the preparation of sulfur- and phosphorus-containing organosilicon compounds |
| 08/14/2001 | US6274747 Polyunsaturated fatty acid derivatives and their use |
| 08/14/2001 | US6274745 Binaphthol monophosphoric acid derivative and its use |
| 08/14/2001 | US6274737 Endothelin receptor antagonists |
| 08/14/2001 | US6274725 Providing compound having a hydroxyl group; reacting with phosphitylating reagent in the presence of a pyridinum salt in a solvent under conditions of time, temperature and pressure to yield phosphitylated compound |
| 08/14/2001 | US6274635 Antitumor agents |
| 08/14/2001 | US6274589 L-β-dioxolane uridine analogs and their pharmaceutical compositions |
| 08/14/2001 | CA2080907C Enzymatic synthesis of soluble phosphatides from phospholipids |
| 08/14/2001 | CA2035179C Pharmaceutical compositions containing insoluble salts of bisphosphonic acids |
| 08/10/2001 | WO2000047595A1 Ether type lipid a1-carboxylic acid analogues |
| 08/10/2001 | CA2362246A1 Ether type lipid a1-carboxylic acid analogues |
| 08/09/2001 | WO2001057052A1 Process for making geminal bisphosphonates |
| 08/09/2001 | WO2001057051A1 Salt of a melamine condensation product and a phosphorus-containing acid |
| 08/09/2001 | WO2001057050A1 Novel phosphorus compounds |
| 08/09/2001 | WO2001057048A1 Silicon containing compounds from michael - type addition reactions useful as monomers and macromers |
| 08/09/2001 | WO2001057047A1 Zwitterionic groups containing compounds from michael-type reactions useful as monomers and macromers |
| 08/09/2001 | WO2001056983A2 Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| 08/09/2001 | WO2001056933A2 Combined supported liquid membrane/strip dispersion processes and extractants |
| 08/09/2001 | WO2001056358A2 Enhanced propertied pesticides |
| 08/09/2001 | WO2000075144A8 Peroxynitrite decomposition catalysts and methods of use thereof |
| 08/09/2001 | WO2000071506A3 Naphthalene ureas as glucose uptake enhancers |
| 08/09/2001 | WO2000066100A3 2r,4s-hydroxyitraconazole isomers |
| 08/09/2001 | WO2000066094A3 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents |
| 08/09/2001 | US20010012895 Therapy for hair loss in mammals; drug resistance; nervous system disorders |
| 08/09/2001 | US20010012893 Acyclovir diester derivatives |
| 08/09/2001 | US20010012857 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 08/09/2001 | DE10105046A1 Metallorganische Monoacyl-Aryl-Phosphine Organometallic monoacyl aryl phosphines |
| 08/09/2001 | CA2398697A1 Salt of a melamine condensation product and a phosphorus-containing acid |
| 08/08/2001 | EP1122258A1 Silicon containing compounds from Michael-type adduct reactions useful as monomers and macromers |
| 08/08/2001 | EP1121474A2 Organocopper precursors for chemical vapor deposition |
| 08/08/2001 | EP1121371A1 Nucleotide compounds including a rigid linker |
| 08/08/2001 | EP1121367A1 Phosphole and diphosphole ligands for catalysis |
| 08/08/2001 | EP1121366A1 Prodrugs of phosphorous-containing pharmaceuticals |
| 08/08/2001 | EP1121358A1 Heterocyclylaminomethyloxazolidinones as antibacterials |
| 08/08/2001 | EP1121337A1 Preparation of cyclopropylethyne and intermediates for preparation of cyclopropylethyne |
| 08/08/2001 | EP0959987B1 Use of perfluoroalkyl substituted phosphorus compounds as ligands for homogeneous catalysis in supercritical carbon dioxide |
| 08/08/2001 | CN1307452A Aqueous extraction process to selectively remove phospholipid from egg yolks |
| 08/08/2001 | CN1306963A Condensation, phospholipids compounds and their derivs, prepared by said condensation |
| 08/08/2001 | CN1069320C High-purity tocopherol phosphates, prep. thereof, and cosmetics containing the compound |
| 08/08/2001 | CA2334291A1 Organometallic monoacylarylphosphines |
| 08/07/2001 | US6271408 Process for making metabolites of lycopene |
| 08/07/2001 | US6271399 Methyl 3-(3,4-methylenedioxyphenyl)-6-(prop-1-yloxy)-indane-2-carboxylate derivatives |
| 08/07/2001 | US6271397 L-ascorbic acid-2-phosphoric acid potassium crystal and method for producing the same |
| 08/07/2001 | US6271378 Process for preparing tricyclic compounds having antihistaminic activity |
| 08/07/2001 | US6271245 Hydroxamic acid derivatives |
| 08/07/2001 | US6271235 HIV protease inhibitors |
| 08/07/2001 | US6271015 A polypeptide having an amino acid sequence that hydrolysizes cis-9,10-octadecenoamide and other soporific fatty acid amides; therapy for sleep disorders and narcolepsy |
| 08/07/2001 | US6270745 Radioactive transition metal nitride heterocomplex |
| 08/07/2001 | US6270695 Heterocyclic compounds with exocyclic double bond having phosphate group attached to distal carbon; detection sensitivity |
| 08/07/2001 | CA2015296C Pyranyl cyanoguanidine derivatives |
| 08/02/2001 | WO2001055156A1 A method of generating a functionalised arylphosphine |
| 08/02/2001 | WO2001055147A1 PYRIDO[2,3-d]PYRIMIDINE-2,7-DIAMINE KINASE INHIBITORS |
| 08/02/2001 | WO2001055124A1 Isothiazolecarboxylic acid derivatives and their use as microbicides |
| 08/02/2001 | WO2001055095A1 Functional monomers for molecular recognition and catalysis |
| 08/02/2001 | WO2001055082A2 Intermediates for biologically active compounds |
| 08/02/2001 | WO2001054694A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method |
| 08/02/2001 | WO2001054481A2 Enhanced propertied pharmaceuticals |
| 08/02/2001 | US20010011145 Preparation of phosphine ligands |
| 08/02/2001 | US20010011140 Reacting a cyclic silyl ether with a halogen functional compound |
| 08/02/2001 | CA2397831A1 Enhanced propertied pharmaceuticals |
| 08/02/2001 | CA2396596A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method |
| 08/01/2001 | EP1120652A1 Enhancement of chemiluminescence in assays |
| 08/01/2001 | EP1120423A1 Improved chemiluminescent 1,2-dioxetanes |
| 08/01/2001 | EP1120422A1 Improved chemiluminescent 1,2-dioxetanes |
| 08/01/2001 | EP1120162A2 Use of catalysts with a higher molecular weight in an asymmetrical continous hydration reaction, ligands and catalysts |
| 08/01/2001 | EP1120122A1 Bone repair materials/artificial bone compositions |
| 08/01/2001 | EP1120117A1 Method of increasing the production of eggs and strengthening eggshells in poultry |
| 08/01/2001 | EP1119574A1 Substituted isophosphindolines and their use |
| 08/01/2001 | EP1119566A1 Novel heterocyclyl-methyl-substituted pyrazoles |